Company News

FEATURED POST

February 11, 2021

MyoStrain® Provides Comprehensive Assessment of Myocardial Deformation to Help Physicians Risk-Stratify Heart Failure Patients for Individualized Cardiac Treatment

A new article published in the European Society of Cardiology (ESC) Heart Failure Journal demonstrated MyoStrain’s ability to accurately detect and delineate patterns of myocardial dysfunction between heart failure (HF) types and severity...

Read more >

February 21, 2021

MyoStrain® and MyoStress™ Presented in Three New Abstracts at SCMR 2021

Myocardial Solutions, Inc. (“MSI”) attended the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th Annual Scientific Sessions, held virtually February 18-20, 2021. This year, SCMR main topics focused on new and traditional use cases of CMR, as well as exploring the use of CMR ...

Read more >

February 17, 2021

Abstract Posters and Presentations Featuring MyoStrain® at SCMR Virtual Scientific Sessions 2021

Myocardial Solutions,Inc. (“MSI”) will attend the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th annual scientific sessions virtually from February 18-21, 2021. The event focuses on highlighting breakthrough developments in new cardiovascular magnetic resonance (CMR) techniques ...

Read more >

January 25, 2021

JACC Cardiovascular Imaging Publishes New Peer-Reviewed Article Validating MyoStrain® for the Detection of Asymptomatic Cardiac Dysfunction and Ability to Risk-Stratify Patients for Individualized Care

A new pivotal research paper published in the Journal of American College of Cardiology (JACC) Cardiovascular Imaging presents several key validations for the clinical use of MyoStrain® in determining the risk of heart failure across multiple cardiac disease states.

Read more >
Philips healthcare presents MyoStrain at RSNA 2020

December 8, 2020

Presentation: Philips Healthcare Presents MyoStrain® at RSNA 2020

Philips Healthcare presented MyoStrain® at RSNA 2020 and discussed how MyoStrain's MRI-based cardiac diagnostic solutions may help transform cardiovascular care and enable physicians to quantify subtle changes in intra-myocardial heart function.

Read more >
MyoStrain Featured at VCOS 2020 Satellite Symposium

October 8, 2020

Myocardial Solutions Sponsors Featured MyoStrain® Satellite Symposium at 2020 Virtual Cardio-Oncology Summit (V-COS)

Myocardial Solutions (MSI) featured MyoStrain® in a satellite symposium at the first ever International Cardio-Oncology Summit 2020, a joint CardioTox and Global Cardio-Oncology Society (GCOS) initiative attracting oncologists, cardiologists, radiologists and pharmacists from around the world to ...

Read more >

September 24, 2020

Society for Cardiovascular Magnetic Resonance Lists Fast-SENC in New CMR-Protocols for Identifying Cardiac Damage in COVID-19 Patients

MyoStrain® was included in a new article published in the Journal of Cardiovascular Magnetic Resonance (JCMR) by the Society of Cardiovascular Magnetic Resonance (SCMR). The paper provides specific and detailed recommendations on the use of cardiovascular magnetic resonance (CMR) protocols for...

Read more >

September 8, 2020

Five New Abstracts, Poster Presentations Featuring MyoStrain® Presented at European Society of Cardiology Congress 2020

Myocardial Solutions (“MSI”) technology MyoStrain® was featured in five unique abstracts and e-poster presentations at the European Society of Cardiology (ESC) virtual congress event from August 29th to September 2nd. The abstracts discussed the diagnostic value and clinical impact of MyoStrain...

Read more >

August 20, 2020

Myocardial Solutions Awarded Most Innovative Cardiology Software Company 2020

Myocardial Solutions, Inc. (“MSI”) was recognized as the Most Innovative Cardiology Software Company of 2020.The award to MSI was published in Acquisition International’s (“AI Global”) annual Global Excellence Awards issue for the month of August. AI Global is a magazine publisher based in the...

Read more >

August 11, 2020

Myocardial Solutions Announces Strategic Partnership with United Imaging, Bringing Rapid Cardiac MR Imaging to Unmet Cancer Care and Cardiology Markets

Myocardial Solutions, Inc. (“MSI”) and United Imaging, Inc. (“United Imaging”) have formed a strategic partnership to open the cancer care and cardiology market for rapid imaging enabling the detection and management of cardiac diseases and the effects of cancer therapies on the heart...

Read more >